Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”

Saved in:
Bibliographic Details
Main Authors: A. Ortiz Brugués, P. Sollena, M. Starace, F. Bardazzi, D. Koumaki, Z. Apalla, M. Iorizzo, C. Bost, S. Milesi, J.L. Lacaze, K. Peris, V. Sibaud
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EJC Skin Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2772611824001848
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846159069227778048
author A. Ortiz Brugués
P. Sollena
M. Starace
F. Bardazzi
D. Koumaki
Z. Apalla
M. Iorizzo
C. Bost
S. Milesi
J.L. Lacaze
K. Peris
V. Sibaud
author_facet A. Ortiz Brugués
P. Sollena
M. Starace
F. Bardazzi
D. Koumaki
Z. Apalla
M. Iorizzo
C. Bost
S. Milesi
J.L. Lacaze
K. Peris
V. Sibaud
author_sort A. Ortiz Brugués
collection DOAJ
format Article
id doaj-art-ef5eb6bdd81d4331a9dcb1ca60c6146d
institution Kabale University
issn 2772-6118
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series EJC Skin Cancer
spelling doaj-art-ef5eb6bdd81d4331a9dcb1ca60c6146d2024-11-24T04:15:12ZengElsevierEJC Skin Cancer2772-61182024-01-012100196Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”A. Ortiz Brugués0P. Sollena1M. Starace2F. Bardazzi3D. Koumaki4Z. Apalla5M. Iorizzo6C. Bost7S. Milesi8J.L. Lacaze9K. Peris10V. Sibaud11Institut Universitaire du Cancer - Oncopole, Toulouse, FranceFondazione Policlinico Universitario, Rome, ItalyOspedale sant'Orsola-Malpighi, Bologna, ItalyOspedale sant'Orsola-Malpighi, Bologna, ItalyUniversity Hospital of Heraklion, Heraklion, GreeceAristotle University of Thessaloniki, Thessaloniki, GreecePrivate Dermatology Practice, Lugano/Bellinzona, SwitzerlandCentre Hospitalier Universitaire, Toulouse, FranceInstitut Universitaire du Cancer - Oncopole, Toulouse, FranceInstitut Universitaire du Cancer - Oncopole, Toulouse, FranceFondazione Policlinico Universitario ''Agostino Gemelli'', Rome, ItalyInstitut Universitaire du Cancer - Oncopole, Toulouse, Francehttp://www.sciencedirect.com/science/article/pii/S2772611824001848
spellingShingle A. Ortiz Brugués
P. Sollena
M. Starace
F. Bardazzi
D. Koumaki
Z. Apalla
M. Iorizzo
C. Bost
S. Milesi
J.L. Lacaze
K. Peris
V. Sibaud
Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”
EJC Skin Cancer
title Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”
title_full Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”
title_fullStr Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”
title_full_unstemmed Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”
title_short Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”
title_sort autoimmune bullous disorders induced by cyclin dependent kinase 4 6 inhibitors first case series from the eadv task force dermatology for cancer patients
url http://www.sciencedirect.com/science/article/pii/S2772611824001848
work_keys_str_mv AT aortizbrugues autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT psollena autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT mstarace autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT fbardazzi autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT dkoumaki autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT zapalla autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT miorizzo autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT cbost autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT smilesi autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT jllacaze autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT kperis autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients
AT vsibaud autoimmunebullousdisordersinducedbycyclindependentkinase46inhibitorsfirstcaseseriesfromtheeadvtaskforcedermatologyforcancerpatients